Suppr超能文献

B细胞淋巴增殖性疾病中细胞外信号调节激酶和p38丝裂原活化蛋白激酶的组成性激活。

Constitutive activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in B-cell lymphoproliferative disorders.

作者信息

Ogasawara Toshie, Yasuyama Masako, Kawauchi Kiyotaka

机构信息

Department of Medicine, Tokyo Women's Medical University, Daini Hospital, Tokyo, Japan.

出版信息

Int J Hematol. 2003 May;77(4):364-70. doi: 10.1007/BF02982645.

Abstract

Signaling molecules such as p21(ras) (Ras), mitogen-activated protein kinase (MAPK), and Akt kinase play pivotal roles in the proliferation and survival of lymphoid cells in response to many kinds of stimulation. It is not fully understood, however, how these molecules participate in the growth of malignant lymphoid cells. We determined whether Ras, MAPKs such as extracellular signal-regulated kinase (ERK), c-Jun amino-terminal kinase (JNK), and p38 MAPK, and Akt kinase are activated in B-cell tumors, including acute lymphoblastic leukemia, chronic lymphocytic leukemia, Burkitt-like lymphoma, diffuse large B-cell lymphoma, and plasma cell leukemia. We found that Lyn protein tyrosine kinase was constitutively phosphorylated on tyrosine, and that ERK and p38 MAPK were constitutively active in all cases of the B-cell tumor. In contrast, activation of Ras and Akt kinase was found in limited cases, and JNK kinase activity was not observed in any case. These results suggest that ERK and p38 play roles in the oncogenesis of B-cell tumors.

摘要

诸如p21(ras)(Ras)、丝裂原活化蛋白激酶(MAPK)和Akt激酶等信号分子在多种刺激下的淋巴细胞增殖和存活中发挥着关键作用。然而,这些分子如何参与恶性淋巴细胞的生长尚未完全明确。我们确定了Ras、细胞外信号调节激酶(ERK)、c-Jun氨基末端激酶(JNK)和p38 MAPK等MAPK以及Akt激酶在包括急性淋巴细胞白血病、慢性淋巴细胞白血病、伯基特样淋巴瘤、弥漫性大B细胞淋巴瘤和浆细胞白血病在内的B细胞肿瘤中是否被激活。我们发现Lyn蛋白酪氨酸激酶在酪氨酸上持续磷酸化,并且ERK和p38 MAPK在所有B细胞肿瘤病例中均持续活跃。相比之下,仅在有限的病例中发现Ras和Akt激酶被激活,在任何病例中均未观察到JNK激酶活性。这些结果表明ERK和p38在B细胞肿瘤的肿瘤发生中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验